Factors associated with the development of cytomegalovirus infection following solid organ transplantation

Scand J Infect Dis. 2011 May;43(5):360-5. doi: 10.3109/00365548.2010.549836. Epub 2011 Feb 9.

Abstract

Background: Infection with cytomegalovirus (CMV) remains a potentially serious complication in transplant patients. In this study we explored the risk factors for CMV infection in the 12 months following a solid organ transplantation (n = 242) in patients monitored for CMV infection from 2004 to 2007.

Methods: CMV infection was defined as 2 consecutive quantifiable CMV-polymerase chain reaction (PCR) values or 1 measurement of >3000 copies/ml. Data describing pre- and post-transplantation variables were extracted from electronic health records. Time to CMV infection was investigated using Cox proportional hazards analysis.

Results: Overall, 31% (75/242) of solid organ transplant patients developed CMV infection: 4/8 (50.0%) heart, 15/43 (34.9%) liver, 30/89 (33.7%) lung and 26/102 (25.5%) kidney transplant patients. The risk of CMV infection according to donor (D)/recipient (R) CMV serostatus (positive + or negative-) was highest for D+/R-(adjusted hazard ratio 2.6, 95% confidence interval 1.6-4.2) vs D+/R+, and was reduced for D-/R+(adjusted hazard ratio 0.2, 95% confidence interval 0.2-0.8) vs D+/R+.

Conclusion: Positive donor CMV-serostatus is a major risk factor for CMV-infection in CMV-na ve recipients, but also in recipients with positive CMV-serostatus. Conversely, if donor is CMV serostatus is negative, the risk of CMV infection is low, irrespective of recipients CMV-serostatus. These findings suggest poorer immune function towards donor-induced strains of CMV versus recipient own latent strains.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood
  • Antiviral Agents / therapeutic use
  • Child
  • Cohort Studies
  • Cytomegalovirus / immunology*
  • Cytomegalovirus / pathogenicity
  • Cytomegalovirus Infections / epidemiology
  • Cytomegalovirus Infections / etiology
  • Cytomegalovirus Infections / immunology*
  • Denmark / epidemiology
  • Female
  • Follow-Up Studies
  • Ganciclovir / therapeutic use
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Male
  • Middle Aged
  • Organ Transplantation / adverse effects*
  • Retrospective Studies
  • Risk Factors
  • Seroepidemiologic Studies
  • Tissue Donors*
  • Young Adult

Substances

  • Antibodies, Viral
  • Antiviral Agents
  • Immunosuppressive Agents
  • Ganciclovir